校准后的乳腺密度测量
本研究在319对匹配病例对照中评估既往开发的校准方法能否产生预测乳腺癌风险的乳腺密度指标。校准PGsd与乳腺癌风险显著相关,效应量与操作者辅助Cumulus法测得的乳腺密度百分比(PD)相当,而校准PGm表现稍差。
要点
- 校准PGsd与乳腺癌风险显著相关,效应量与Cumulus法PD相当。
- 校准PGm与乳腺癌风险关联稍弱且未达统计学显著。
- 校准方法在更一般条件下可重复既往结果。
核心结论
- 校准PGsd测量与乳腺癌风险显著相关,效应量与PD相当;校准PGm表现稍差;既往开发的校准方法在更一般条件下可重复。
研究设计与样本
- 匹配病例对照研究,319对;二维乳腺X线图像来自6台Hologic乳腺摄影设备(3台Selenia二维全视野数字乳腺X线摄影系统和3台Dimensions数字乳腺断层合成系统);参考标准为操作者辅助Cumulus法测定的乳腺密度百分比(PD);匹配变量包括年龄、激素替代治疗使用/时长、筛查史和乳腺摄影设备。
诊断标准与关键数值
- 在校正模型中,PGsd连续测量OR 1.34(95%CI 1.09-1.66),Q2-Q4的OR分别为1.83(1.11-3.02)、2.19(1.28-3.73)、2.20(1.26-3.85);PD连续测量OR 1.43(1.16-1.76),Q2-Q4的OR分别为0.84(0.52-1.38)、1.96(1.19-3.23)、2.27(1.29-4.00);PGsd与PD的Az均为0.61-0.62。
临床应用与阅片要点
- 在校正模型中,校准PGsd与乳腺癌风险显著相关,效应量与Cumulus法PD相当,校准PGm关联稍弱且未达统计学显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Mammographic density is an important risk factor for breast cancer, but translation to the clinic requires assurance that prior work based on mammography is applicable to current technologies. The purpose of this work is to evaluate whether a calibration methodology developed previously produces breast density metrics predictive of breast cancer risk when applied to a case-control study.
MATERIALS AND METHODS: A matched case control study (n = 319 pairs) was used to evaluate two calibrated measures of breast density. Two-dimensional mammograms were acquired from six Hologic mammography units: three conventional Selenia two-dimensional full-field digital mammography systems and three Dimensions digital breast tomosynthesis systems. We evaluated the capability of two calibrated breast density measures to quantify breast cancer risk: the mean (PGm) and standard deviation (PGsd) of the calibrated pixels. Matching variables included age, hormone replacement therapy usage/duration, screening history, and mammography unit. Calibrated measures were compared to the percentage of breast density (PD) determined with the operator-assisted Cumulus method. Conditional logistic regression was used to generate odds ratios (ORs) from continuous and quartile (Q) models with 95% confidence intervals. The area under the receiver operating characteristic curve (Az) was also used as a comparison metric. Both univariate models and models adjusted for body mass index and ethnicity were evaluated.
RESULTS: In adjusted models, both PGsd and PD were statistically significantly associated with breast cancer with similar Az of 0.61-0.62. The corresponding ORs and confidence intervals were also similar. For PGsd, the OR was 1.34 (1.09, 1.66) for the continuous measure and 1.83 (1.11, 3.02), 2.19 (1.28, 3.73), and 2.20 (1.26, 3.85) for Q2-Q4. For PD, the OR was 1.43 (1.16, 1.76) for the continuous measure and 0.84 (0.52, 1.38), 1.96 (1.19, 3.23), and 2.27 (1.29, 4.00) for Q2-Q4. The results for PGm were slightly attenuated and not statistically significant. The OR was 1.22 (0.99, 1.51) with Az = 0.60 for the continuous measure and 1.24 (0.78, 1.97), 0.98 (0.60, 1.61), and 1.26, (0.77, 2.07) for Q2-Q4 with Az = 0.60.
CONCLUSION: The calibrated PGsd measure provided significant associations with breast cancer comparable to those given by PD. The calibrated PGm performed slightly worse. These findings indicate that the calibration approach developed previously replicates under more general conditions.
引用
- Fowler EE, Smallwood A, Khan N, et al. Calibrated Breast Density Measurements. Acad Radiol. 2018. PMID: 30545682. doi:10.1016/j.acra.2018.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。